# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000320017-25-000024
Filing Date
2025-04-25
Accepted
2025-04-25 16:12:11
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | defa14anotice20250425.htm | DEFA14A | 11598
2 |  | notice-page1.jpg | GRAPHIC | 6018150
3 |  | notice-page2.jpg | GRAPHIC | 5253624
| Complete submission text file | 0000320017-25-000024.txt |  | 15537975

Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33650 | Film No.: 25874100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)